Intracystic bleomycin for cystic craniopharyngiomas in children
Referencias
Additional references
Broggi G, Giorgi C, Franzini A, Servello D, Solero CL. Preliminary results of intracavitary treatment of craniopharyngioma with bleomycin. Journal of Neurosurgical Sciences 1989;33:145‐8.
Bunin GR, Surawicz TS, Witman PA, Preston‐Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 1996;89:547‐51.
DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34.
Gleeson HK, Stoeter R, Ogilvy‐Stuart AL. Improvements in final height over 25 years in growth hormone (GH)‐deficient childhood survivors of brain tumors receiving GH replacement. Journal of Clinical Endocrinology & Metabolism 2003;88(8):3682‐9.
Hetelekidis S, Barnes PD, Tao ML. 20‐year experience in childhood craniopharyngioma. International Journal of Radiation Oncology, Biology, Physics 1993;27(2):189‐95.
Higgins JPT, Altman DG (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration, 2009.
Kremer LCM, Van Dalen EC, Moher D, Caron HN. Childhood Cancer Group. The Cochrane Library, Issue 3, 2010. Chichester: Wiley‐Blackwell. Updated monthly2010, issue 3.
Kubo O, Takakura K, Miki Y. Intracystic therapy of bleomycin for craniopharyngioma effect of bleomycin for cultured craniopharyngioma cells and intracystic concentration of bleomycin. No Shinkei Geka 1971;2:683‐8.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719‐48.
Mettolese C, Stan H, HermierM. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Child's Nervous System 2001;17:724‐30.
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurologic Clinics 1991;9:453‐65.
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non‐randomized studies (minors): development and validation of a new instrument. ANZ Journal of Surgery 2003;73(9):712‐6.
Takahashi H, Nakazawa S, Shimura T. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. Journal of Neurosurgery 1985;62:120‐7.
Umezawa H, Maeda K, Takeuchi Y. New antibiotics, bleomycin A and B. Journal of Antibiotics (Tokyo) 1966;19:200‐9.
Wara WM, Sneed PK, David A. The role of radiation therapy in the treatment of craniopharyngioma. Pediatric Neurosurgery 1994;21(suppl.1):98‐100.
Weiner HL, Wisoff JH, Rosenberg ME. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994;35:1001‐11.
Yasargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long‐term results in 144 patients. Journal of Neurosurgery 1990;73:3‐11.
